XML 92 R30.htm IDEA: XBRL DOCUMENT v3.20.1
DERIVATIVES (Tables)
3 Months Ended
Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments by Category
The tables below present quantitative disclosures about the Company’s derivative instruments, including those embedded in other contracts required to be accounted for as derivative instruments.
Derivative Instruments by Category
 
At March 31, 2020
 
Three Months Ended March 31, 2020
 
 
 
Fair Value
 
 
 Notional Amount
 
 Derivative Assets
 
 Derivative Liabilities
 
Net Derivative Gains (Losses) (2)
 
(in millions)
Derivative instruments:
 
 
 
 
 
 
 
Freestanding derivatives (1):
 
 
 
 
 
 
 
Equity contracts:
 
 
 
 
 
 
 
Futures
$
6,317

 
$
2

 
$
5

 
$
220

Swaps
12,947

 
585

 
124

 
3,778

Options
30,050

 
2,547

 
3,086

 
(3,851
)
Interest rate contracts:
 
 
 
 
 
 
 
Swaps
22,896

 
2,475

 
343

 
3,578

Futures
26,713

 

 

 
1,988

Swaptions

 

 

 
9

Credit contracts:
 
 
 
 
 
 
 
Credit default swaps
1,507

 
26

 
22

 
(1
)
Other freestanding contracts:
 
 
 
 
 
 
 
Foreign currency contracts
430

 
9

 
8

 
(2
)
Margin

 
107

 
171

 

Collateral

 
29

 
3,757

 

 
 
 
 
 
 
 
 
Embedded derivatives:
 
 
 
 
 
 
 
GMIB reinsurance contracts (3)

 
2,823

 

 
726

GMxB derivative features liability (4)

 

 
9,727

 
(1,198
)
SCS, SIO, MSO and IUL indexed features (5)

 

 
(940
)
 
4,154

Total derivative instruments
$
100,860

 
$
8,603

 
$
16,303

 


 
 
 
 
 
 
 
 
Net derivative gains (losses)
 
 
 
 
 
 
$
9,401

______________
(1)
Reported in Other invested assets in the consolidated balance sheets.
(2)
Reported in Net derivative gains (losses) in the consolidated statements of income (loss).
(3)
Reported in GMIB reinsurance contract asset in the consolidated balance sheets.
(4)
Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets.
(5)
Reported in Policyholders’ account balances in the consolidated balance sheets.
Derivative Instruments by Category
 
At December 31, 2019
 
Three Months Ended March 31, 2019
 
 
 
Fair Value
 
 
 Notional Amount
 
Derivative Assets
 
Derivative
Liabilities
 
Net Derivative
Gains (Losses) (2)
 
(in millions)
Derivative instruments:
 
 
 
 
 
 
 
Freestanding derivatives (1):
 
 
 
 
 
 
 
Equity contracts:
 
 
 
 
 
 
 
Futures
$
4,257

 
$
1

 
$
1

 
$
(762
)
Swaps
17,156

 
9

 
281

 
(985
)
Options
47,861

 
5,098

 
1,752

 
1,111

Interest rate contracts:
 
 
 
 
 
 
 
Swaps
23,793

 
468

 
526

 
648

Futures
20,901

 

 

 
56

Swaptions
3,201

 
16

 

 

Credit contracts:
 
 
 
 
 
 
 
Credit default swaps
1,400

 
21

 
6

 
7

Other freestanding contracts:
 
 
 
 
 
 
 
Foreign currency contracts
559

 
12

 
9

 
10

Margin

 
155

 

 

Collateral

 
74

 
3,016

 

 
 
 
 
 
 
 
 
Embedded derivatives:

 
 
 
 
 
 
 
GMIB reinsurance contracts (3)
 
 
2,139

 

 
18

GMxB derivative features liability (4)

 

 
8,432

 
(408
)
SCS, SIO, MSO and IUL indexed features (5)

 

 
3,268

 
(1,325
)
Total derivative instruments
$
119,128

 
$
7,993

 
$
17,291

 


 
 
 
 
 
 
 
 
Net derivative gains (losses)
 
 
 
 
 
 
$
(1,630
)
______________
(1)
Reported in Other invested assets in the consolidated balance sheets.
(2)
Reported in Net derivative gains (losses) in the consolidated statements of income (loss).
(3)
Reported in GMIB reinsurance contract asset in the consolidated balance sheets.
(4)
Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets.
(5)
Reported in Policyholders’ account balances in the consolidated balance sheets.
Offsetting Financial Assets and Liabilities and Derivative Instruments
The following table presents information about the Company’s offsetting of financial assets and liabilities and derivative instruments at March 31, 2020:
Offsetting of Financial Assets and Liabilities and Derivative Instruments
At March 31, 2020
 
Gross Amount Recognized
 
Gross Amount Offset in the Balance Sheets
 
Net Amount Presented in the Balance Sheets
 
Gross Amount not Offset in the Balance Sheets (3)
 
Net Amount
 
(in millions)
Assets:
 
 
 
 
 
 
 
 
 
Derivative assets (1)
$
5,779

 
$
5,522

 
$
257

 
$
(162
)
 
$
95

Other financial assets
1,855

 

 
1,855

 

 
1,855

Other invested assets
$
7,634

 
$
5,522

 
$
2,112

 
$
(162
)
 
$
1,950

 
 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
Derivative liabilities (2)
$
7,354

 
$
5,522

 
$
1,832

 
$

 
$
1,832

Other financial liabilities
3,884

 

 
3,884

 

 
3,884

Other liabilities
$
11,238

 
$
5,522

 
$
5,716

 
$

 
$
5,716

______________
(1)
Excludes Investment Management and Research segment’s derivative assets of consolidated VIEs/VOEs.
(2)
Excludes Investment Management and Research segment’s derivative liabilities of consolidated VIEs/VOEs.
(3)
Primarily financial instrument sent (held).
The following table presents information about the Company’s offsetting of financial assets and liabilities and derivative instruments at December 31, 2019:
Offsetting of Financial Assets and Liabilities and Derivative Instruments
At December 31, 2019
 
Gross Amount Recognized
 
Gross Amount Offset in the Balance Sheets
 
Net Amount Presented in the Balance Sheets
 
Gross Amount not Offset in the Balance Sheets (3)
 
Net Amount
 
(in millions)
Assets:
 
 
 
 
 
 
 
 
 
Derivative assets (1)
$
5,852

 
$
5,466

 
$
386

 
$
(77
)
 
$
309

Other financial instruments
2,394

 

 
2,394

 

 
2,394

Other invested assets
$
8,246

 
$
5,466

 
$
2,780

 
$
(77
)
 
$
2,703

 
 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
Derivative liabilities (2)
$
5,512

 
$
5,466

 
$
46

 
$

 
$
46

Other financial liabilities
3,924

 

 
3,924

 

 
3,924

Other liabilities
$
9,436

 
$
5,466

 
$
3,970

 
$

 
$
3,970

______________
(1)
Excludes Investment Management and Research segment’s derivative assets of consolidated VIEs/VOEs.
(2)
Excludes Investment Management and Research segment’s derivative liabilities of consolidated VIEs/VOEs.
(3)     Primarily financial instrument sent (held).